BIOTRONIK has released new sizes of the Pulsar-18 stent for treatment within the superficial femoral artery and infrapopliteal arteries, making it available in sizes from 4 mm to 7 mm in diameter and from 20 mm to 200 mm in length.
The self expanding stent is compatible with 4F size delivery devices.
More from the press release:
The stent has an improved radial force, flexibility and fracture-resistance when compared with competitor devices, as well as the previously successful Astron Pulsar stent, which it is replacing. This is especially important in the SFA where stiffer, previous-generation stents have, according to the data, offered only moderate results. The 4EVER study recently completed its enrollment of 120 patients and will be looking to provide clinical data to support the improved efficacy of this fifth-generation stent design. The results after six months of follow-up are expected to be presented first at The Leipzig Interventional Course, LINC 2012, January 25–28, 2012.
Available on a 0.018″/4 F platform, the new product release completes the “4 F solutions” portfolio that the company has created. When used together with the 0.018″ Cruiser-18 wire, 4 F Fortress sheath and 0.018″/4 F Passeo-18, minimally invasive intervention of the lower limb is now truly possible for short through intermediate and even long lesions. With the ever-increasing interest by physicians to treat more complex and longer lesions, the Pulsar-18 stent system is a single device for all infrainguinal stenting—thus minimizing inventory and maximizing efficiency.
Press release: BIOTRONIK Launches First 20 mm–200 mm Stents on 4 F Platform for Treatment of SFA and BTK Disease …
